Francois Rousseau, based in Paris, Île-De-France, France, is currently a Chief Development Officer (CDO) at DiogenX, bringing experience from previous roles at Alentis Therapeutics, Galderma, Nestlé Skin Health and Glenmark Pharmaceuticals. Francois Rousseau holds a 2021 - 2022 Leadership essentials programs in IMD certificate @ IMD. With a robust skill set that includes Molecular Biology, Protein Expression, Molecular Cloning, Protein Purification, Biotechnology and more, Francois Rousseau contributes valuable insights to the industry. Francois Rousseau has 2 emails on RocketReach.